{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:03:45Z","timestamp":1775059425393,"version":"3.50.1"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05661-x","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:32:32Z","timestamp":1768419152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Receptor-Interacting Protein Kinase 1 (RIPK1): A Potential Therapeutic Target in Ischemic Stroke"],"prefix":"10.1007","volume":"63","author":[{"given":"Zijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weirong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"5661_CR1","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung TW, de Leeuw FE (2024) Stroke. Lancet 403:2820\u20132836","journal-title":"Lancet"},{"key":"5661_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Beaton AZ et al (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147:e93\u2013e621","journal-title":"Circulation"},{"key":"5661_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","volume":"7","author":"C Qin","year":"2022","unstructured":"Qin C, Yang S, Chu YH, Zhang H, Pang XW, Chen L, Zhou LQ, Chen M et al (2022) Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 7:215","journal-title":"Signal Transduct Target Ther"},{"key":"5661_CR4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(18)31874-9","volume":"392","author":"C Zerna","year":"2018","unstructured":"Zerna C, Thomalla G, Campbell BCV, Rha J-H, Hill MD (2018) Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke. Lancet 392:1247\u20131256","journal-title":"Lancet"},{"key":"5661_CR5","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1007\/s12035-024-03981-4","volume":"61","author":"Y Xu","year":"2024","unstructured":"Xu Y, Lin F, Liao G, Sun J, Chen W, Zhang L (2024) Ripks and neuroinflammation. Mol Neurobiol 61:6771\u20136787","journal-title":"Mol Neurobiol"},{"key":"5661_CR6","doi-asserted-by":"publisher","first-page":"1401038","DOI":"10.3389\/fnagi.2024.1401038","volume":"16","author":"X Song","year":"2024","unstructured":"Song X, Lan Y, Lv S, Wang Y, Chen L, Lu T, Liu F, Peng D (2024) Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice. Front Aging Neurosci 16:1401038","journal-title":"Front Aging Neurosci"},{"key":"5661_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41419-020-02770-w","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li M, Li X, Zhang H, Wang L, Wu X, Zhang H, Luo Y (2020) Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation. Cell Death Dis 11:565","journal-title":"Cell Death Dis"},{"key":"5661_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1:112\u2013119","journal-title":"Nat Chem Biol"},{"key":"5661_CR9","doi-asserted-by":"publisher","first-page":"103750","DOI":"10.1016\/j.drudis.2023.103750","volume":"28","author":"S Pati","year":"2023","unstructured":"Pati S, Singh Gautam A, Dey M, Tiwari A, Kumar Singh R (2023) Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer\u2019s disease. Drug Discov Today 28:103750","journal-title":"Drug Discov Today"},{"key":"5661_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fphar.2018.00432","volume":"9","author":"Z Lu","year":"2018","unstructured":"Lu Z, Wang H, Zhu M, Song W, Wang J, Wu C, Kong Y, Guo J et al (2018) Ophiopogonin D\u2019, a natural product from Radix Ophiopogonis, induces in vitro and in vivo RIPK1-dependent and caspase-independent apoptotic death in androgen-independent human prostate cancer cells. Front Pharmacol 9:432","journal-title":"Front Pharmacol"},{"key":"5661_CR11","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/ibd\/izab190","volume":"27","author":"Y Li","year":"2021","unstructured":"Li Y, Chen J, Bolinger AA, Chen H, Liu Z, Cong Y, Brasier AR, Pinchuk IV et al (2021) Target-based small molecule drug discovery towards novel therapeutics for inflammatory bowel diseases. Inflamm Bowel Dis 27:S38-s62","journal-title":"Inflamm Bowel Dis"},{"key":"5661_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M, Ch\u2019en IL, Korkina O, Teng X, Abbott D, Cuny GD et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313\u2013321","journal-title":"Nat Chem Biol"},{"key":"5661_CR13","doi-asserted-by":"publisher","first-page":"165552","DOI":"10.1016\/j.bbadis.2019.165552","volume":"1865","author":"K Abe","year":"2019","unstructured":"Abe K, Yano T, Tanno M, Miki T, Kuno A, Sato T, Kouzu H, Nakata K et al (2019) mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. Biochim Biophys Acta Mol Basis Dis 1865:165552","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5661_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41467-020-15466-8","volume":"11","author":"L Laurien","year":"2020","unstructured":"Laurien L, Nagata M, Sch\u00fcnke H, Delanghe T, Wiederstein JL, Kumari S, Schwarzer R, Corona T et al (2020) Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation. Nat Commun 11:1747","journal-title":"Nat Commun"},{"issue":"631","key":"5661_CR15","doi-asserted-by":"publisher","first-page":"eaay7066","DOI":"10.1126\/scisignal.aay7066","volume":"13","author":"K Moriwaki","year":"2020","unstructured":"Moriwaki K, Balaji S, Ka-Ming Chan F (2020) The death-inducing activity of RIPK1 is regulated by the pH environment. Sci Signal 13(631):eaay7066. https:\/\/doi.org\/10.1126\/scisignal.aay7066","journal-title":"Sci Signal"},{"key":"5661_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41418-024-01385-4","volume":"32","author":"R Ni","year":"2025","unstructured":"Ni R, Cao T, Ji X, Peng A, Zhang Z, Fan GC, Stathopulos P, Chakrabarti S et al (2025) DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis. Cell Death Differ 32:306\u2013319","journal-title":"Cell Death Differ"},{"key":"5661_CR17","doi-asserted-by":"publisher","first-page":"117268","DOI":"10.1016\/j.ecoenv.2024.117268","volume":"287","author":"Z Liu","year":"2024","unstructured":"Liu Z, Cui Z, Li C, Lu K, Chen K, Cui W, Wu Y, Xia D (2024) Exposure to perfluorodecanoic acid impairs follicular development via inducing granulosa cell necroptosis. Ecotoxicol Environ Saf 287:117268","journal-title":"Ecotoxicol Environ Saf"},{"key":"5661_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s42003-020-01603-y","volume":"4","author":"O Nakabayashi","year":"2021","unstructured":"Nakabayashi O, Takahashi H, Moriwaki K, Komazawa-Sakon S, Ohtake F, Murai S, Tsuchiya Y, Koyahara Y et al (2021) MIND bomb 2 prevents RIPK1 kinase activity-dependent and -independent apoptosis through ubiquitylation of cFLIP(L). Commun Biol 4:80","journal-title":"Commun Biol"},{"key":"5661_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/BJ20130860","volume":"456","author":"T McQuade","year":"2013","unstructured":"McQuade T, Cho Y, Chan FK (2013) Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis. Biochem J 456:409\u2013415","journal-title":"Biochem J"},{"key":"5661_CR20","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/s41467-019-09690-0","volume":"10","author":"Y Dondelinger","year":"2019","unstructured":"Dondelinger Y, Delanghe T, Priem D, Wynosky-Dolfi MA, Sorobetea D, Rojas-Rivera D, Giansanti P, Roelandt R et al (2019) Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat Commun 10:1729","journal-title":"Nat Commun"},{"key":"5661_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molcel.2015.07.032","volume":"60","author":"Y Dondelinger","year":"2015","unstructured":"Dondelinger Y, Jouan-Lanhouet S, Divert T, Theatre E, Bertin J, Gough PJ, Giansanti P, Heck AJ et al (2015) NF-\u03baB-independent role of IKK\u03b1\/IKK\u03b2 in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling. Mol Cell 60:63\u201376","journal-title":"Mol Cell"},{"key":"5661_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cyto.2015.10.014","volume":"78","author":"CP Dillon","year":"2016","unstructured":"Dillon CP, Balachandran S (2016) StIKking it to a death kinase: IKKs prevent TNF-\u03b1-induced cell death by phosphorylating RIPK1. Cytokine 78:47\u201350","journal-title":"Cytokine"},{"key":"5661_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-025-01726-x","volume":"18","author":"J Tang","year":"2025","unstructured":"Tang J, Zhuang Y, Zhang Y, Hu H, Wang H, Xu H, Li Y, Tu C (2025) Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J Hematol Oncol 18:77","journal-title":"J Hematol Oncol"},{"key":"5661_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","volume":"66","author":"I Jaco","year":"2017","unstructured":"Jaco I, Annibaldi A, Lalaoui N, Wilson R, Tenev T, Laurien L, Kim C, Jamal K et al (2017) MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol Cell 66:698-710.e695","journal-title":"Mol Cell"},{"key":"5661_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ncb3614","volume":"19","author":"MB Menon","year":"2017","unstructured":"Menon MB, Gropengie\u00dfer J, Fischer J, Novikova L, Deuretzbacher A, Lafera J, Schimmeck H, Czymmeck N et al (2017) p38(MAPK)\/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. Nat Cell Biol 19:1248\u20131259","journal-title":"Nat Cell Biol"},{"key":"5661_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-00406-w","volume":"8","author":"J Geng","year":"2017","unstructured":"Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, Mookhtiar AK, Zhao H et al (2017) Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun 8:359","journal-title":"Nat Commun"},{"key":"5661_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ncb3608","volume":"19","author":"Y Dondelinger","year":"2017","unstructured":"Dondelinger Y, Delanghe T, Rojas-Rivera D, Priem D, Delvaeye T, Bruggeman I, Van Herreweghe F, Vandenabeele P et al (2017) MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nat Cell Biol 19:1237\u20131247","journal-title":"Nat Cell Biol"},{"key":"5661_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2017.1396389","volume":"5","author":"MB Menon","year":"2018","unstructured":"Menon MB, Gropengie\u00dfer J, Ruckdeschel K, Gaestel M (2018) To die or not to die: regulatory feedback phosphorylation circuits determine receptor-interacting protein kinase-1 (RIPK1) function. Mol Cell Oncol 5:e1396389","journal-title":"Mol Cell Oncol"},{"key":"5661_CR29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1074\/mcp.M117.068189","volume":"16","author":"F Mohideen","year":"2017","unstructured":"Mohideen F, Paulo JA, Ordureau A, Gygi SP, Harper JW (2017) Quantitative phospho-proteomic analysis of TNF\u03b1\/NF\u03baB signaling reveals a role for RIPK1 phosphorylation in suppressing necrotic cell death. Mol Cell Proteomics 16:1200\u20131216","journal-title":"Mol Cell Proteomics"},{"key":"5661_CR30","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1080\/15548627.2020.1783110","volume":"16","author":"W Wu","year":"2020","unstructured":"Wu W, Stork B (2020) Regulating RIPK1: another way in which ULK1 contributes to survival. Autophagy 16:1544\u20131546","journal-title":"Autophagy"},{"key":"5661_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34080-4","volume":"13","author":"H Tu","year":"2022","unstructured":"Tu H, Xiong W, Zhang J, Zhao X, Lin X (2022) Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. Nat Commun 13:6603","journal-title":"Nat Commun"},{"key":"5661_CR32","doi-asserted-by":"publisher","first-page":"115072","DOI":"10.1016\/j.expneurol.2024.115072","volume":"384","author":"D Jiajia","year":"2025","unstructured":"Jiajia D, Wen Y, Enyan J, Xiaojian Z, Zhen F, Jia Z, Jikai W, Xiaoxin Y et al (2025) PGAM5 promotes RIPK1-PANoptosome activity by phosphorylating and activating RIPK1 to mediate PANoptosis after subarachnoid hemorrhage in rats. Exp Neurol 384:115072","journal-title":"Exp Neurol"},{"issue":"5","key":"5661_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s1074-7613(03)00092-x","volume":"18","author":"DF Legler","year":"2003","unstructured":"Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18(5):655\u2013664. https:\/\/doi.org\/10.1016\/s1074-7613(03)00092-x","journal-title":"Immunity"},{"issue":"3","key":"5661_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s1074-7613(00)80183-1","volume":"12","author":"SQ Zhang","year":"2000","unstructured":"Zhang SQ, Kovalenko A, Cantarella G, Wallach D (2000) Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12(3):301\u2013311. https:\/\/doi.org\/10.1016\/s1074-7613(00)80183-1","journal-title":"Immunity"},{"issue":"1\u20133","key":"5661_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.febslet.2004.04.021","volume":"566","author":"SM Park","year":"2004","unstructured":"Park SM, Yoon JB, Lee TH (2004) Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett 566(1\u20133):151\u20136. https:\/\/doi.org\/10.1016\/j.febslet.2004.04.021","journal-title":"FEBS Lett"},{"key":"5661_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.149","author":"R Weinlich","year":"2016","unstructured":"Weinlich R, Oberst A, Beere HM, Green DR (2016) Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/nrm.2016.149","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5661_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.molcel.2009.10.013","volume":"36","author":"TL Haas","year":"2009","unstructured":"Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E, Feltham R, Vince J et al (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36:831\u2013844","journal-title":"Mol Cell"},{"key":"5661_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ncb1821","volume":"11","author":"F Tokunaga","year":"2009","unstructured":"Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M et al (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11:123\u2013132","journal-title":"Nat Cell Biol"},{"key":"5661_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature09814","volume":"471","author":"F Ikeda","year":"2011","unstructured":"Ikeda F, Deribe YL, Sk\u00e5nland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P et al (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-\u03baB activity and apoptosis. Nature 471:637\u2013641","journal-title":"Nature"},{"key":"5661_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature09815","volume":"471","author":"F Tokunaga","year":"2011","unstructured":"Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S, Tanaka K, Nakano H et al (2011) SHARPIN is a component of the NF-\u03baB-activating linear ubiquitin chain assembly complex. Nature 471:633\u2013636","journal-title":"Nature"},{"key":"5661_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41419-024-07199-z","volume":"15","author":"Y Toda","year":"2024","unstructured":"Toda Y, Fujita H, Mino K, Koyama T, Matsuoka S, Kaizuka T, Agawa M, Matsumoto S et al (2024) Synergistic involvement of the NZF domains of the LUBAC accessory subunits HOIL-1L and SHARPIN in the regulation of LUBAC function. Cell Death Dis 15:813","journal-title":"Cell Death Dis"},{"issue":"50","key":"5661_CR42","doi-asserted-by":"publisher","first-page":"e2001602118","DOI":"10.1073\/pnas.2001602118","volume":"118","author":"RL Ang","year":"2021","unstructured":"Ang RL, Chan M, Legarda D, Sundberg JP, Sun SC, Gillespie VL, Chun N, Heeger PS et al (2021) Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death. Proc Natl Acad Sci U S A 118(50):e2001602118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00722-7","author":"Y Meng","year":"2021","unstructured":"Meng Y, Sandow JJ, Czabotar PE, Murphy JM (2021) The regulation of necroptosis by post-translational modifications. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-020-00722-7","journal-title":"Cell Death Differ"},{"key":"5661_CR44","doi-asserted-by":"publisher","first-page":"13636","DOI":"10.1074\/jbc.M600620200","volume":"281","author":"H Li","year":"2006","unstructured":"Li H, Kobayashi M, Blonska M, You Y, Lin X (2006) Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem 281:13636\u201313643","journal-title":"J Biol Chem"},{"key":"5661_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41418-020-00629-3","volume":"28","author":"M Kist","year":"2021","unstructured":"Kist M, K\u0151m\u0171ves LG, Goncharov T, Dugger DL, Yu C, Roose-Girma M, Newton K, Webster JD et al (2021) Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death. Cell Death Differ 28:985\u20131000","journal-title":"Cell Death Differ"},{"key":"5661_CR46","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1038\/s41467-020-19935-y","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Zhang M, Huang X, Liang W, Li G, Lu X, Li Y, Pan H et al (2020) Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun 11:6364","journal-title":"Nat Commun"},{"key":"5661_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1126\/science.aaf6803","volume":"353","author":"Y Ito","year":"2016","unstructured":"Ito Y, Ofengeim D, Najafov A, Das S, Saberi S, Li Y, Hitomi J, Zhu H et al (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353:603\u2013608","journal-title":"Science"},{"key":"5661_CR48","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1042\/BCJ20210725","volume":"479","author":"E Varfolomeev","year":"2022","unstructured":"Varfolomeev E, Vucic D (2022) RIP1 post-translational modifications. Biochem J 479:929\u2013951","journal-title":"Biochem J"},{"key":"5661_CR49","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.ajpath.2017.04.015","volume":"187","author":"K Dong","year":"2017","unstructured":"Dong K, Han L, Liu J, Wang F, Sun X (2017) RNA interference reveals the coregulatory effects of Cylindromatosis on apoptosis and necroptosis of photoreceptor cells in experimental retinal detachment. Am J Pathol 187:1763\u20131771","journal-title":"Am J Pathol"},{"key":"5661_CR50","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O\u2019Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C et al (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694\u2013699","journal-title":"Nature"},{"key":"5661_CR51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1126\/science.1182364","volume":"327","author":"N Shembade","year":"2010","unstructured":"Shembade N, Ma A, Harhaj EW (2010) Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327:1135\u20131139","journal-title":"Science"},{"key":"5661_CR52","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41419-019-1937-y","volume":"10","author":"D Priem","year":"2019","unstructured":"Priem D, Devos M, Druw\u00e9 S, Martens A, Slowicka K, Ting AT, Pasparakis M, Declercq W et al (2019) A20 protects cells from TNF-induced apoptosis through linear ubiquitin-dependent and -independent mechanisms. Cell Death Dis 10:692","journal-title":"Cell Death Dis"},{"key":"5661_CR53","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1074\/jbc.M708690200","volume":"283","author":"K Enesa","year":"2008","unstructured":"Enesa K, Zakkar M, Chaudhury H, le Luong A, Rawlinson L, Mason JC, Haskard DO, Dean JL et al (2008) NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 283:7036\u20137045","journal-title":"J Biol Chem"},{"key":"5661_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41419-023-06014-5","volume":"14","author":"K Harit","year":"2023","unstructured":"Harit K, Bhattacharjee R, Matuschewski K, Becker J, Kalinke U, Schl\u00fcter D, Nishanth G (2023) The deubiquitinating enzyme OTUD7b protects dendritic cells from TNF-induced apoptosis by stabilizing the E3 ligase TRAF2. Cell Death Dis 14:480","journal-title":"Cell Death Dis"},{"key":"5661_CR55","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1074\/jbc.M109.042689","volume":"285","author":"G Xu","year":"2010","unstructured":"Xu G, Tan X, Wang H, Sun W, Shi Y, Burlingame S, Gu X, Cao G et al (2010) Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. J Biol Chem 285:969\u2013978","journal-title":"J Biol Chem"},{"key":"5661_CR56","doi-asserted-by":"publisher","first-page":"e0117304","DOI":"10.1371\/journal.pone.0117304","volume":"10","author":"J Pannu","year":"2015","unstructured":"Pannu J, Belle JI, F\u00f6rster M, Duerr CU, Shen S, Kane L, Harcourt K, Fritz JH et al (2015) Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE 10:e0117304","journal-title":"PLoS ONE"},{"key":"5661_CR57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41419-023-06170-8","volume":"14","author":"W Xinyu","year":"2023","unstructured":"Xinyu W, Qian W, Yanjun W, Jingwen K, Keying X, Jiazheng J, Haibing Z, Kai W et al (2023) Polarity protein AF6 functions as a modulator of necroptosis by regulating ubiquitination of RIPK1 in liver diseases. Cell Death Dis 14:673","journal-title":"Cell Death Dis"},{"key":"5661_CR58","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.celrep.2019.11.014","volume":"29","author":"T Douglas","year":"2019","unstructured":"Douglas T, Saleh M (2019) Post-translational modification of OTULIN regulates ubiquitin dynamics and cell death. Cell Rep 29:3652-3663.e3655","journal-title":"Cell Rep"},{"key":"5661_CR59","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1080\/15548627.2020.1781393","volume":"17","author":"Y Chu","year":"2021","unstructured":"Chu Y, Kang Y, Yan C, Yang C, Zhang T, Huo H, Liu Y (2021) LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13. Autophagy 17:1684\u20131699","journal-title":"Autophagy"},{"key":"5661_CR60","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1038\/s41467-021-25945-1","volume":"12","author":"H Sch\u00fcnke","year":"2021","unstructured":"Sch\u00fcnke H, G\u00f6bel U, Dikic I, Pasparakis M (2021) OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice. Nat Commun 12:5912","journal-title":"Nat Commun"},{"key":"5661_CR61","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1101\/gad.13.19.2514","volume":"13","author":"Y Lin","year":"1999","unstructured":"Lin Y, Devin A, Rodriguez Y, Liu ZG (1999) Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514\u20132526","journal-title":"Genes Dev"},{"key":"5661_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19839-4","volume":"8","author":"SN Croft","year":"2018","unstructured":"Croft SN, Walker EJ, Ghildyal R (2018) Human rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation. Sci Rep 8:1569","journal-title":"Sci Rep"},{"key":"5661_CR63","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1038\/sj.onc.1203796","volume":"19","author":"JW Kim","year":"2000","unstructured":"Kim JW, Choi EJ, Joe CO (2000) Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 19:4491\u20134499","journal-title":"Oncogene"},{"key":"5661_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","volume":"577","author":"N Lalaoui","year":"2020","unstructured":"Lalaoui N, Boyden SE, Oda H, Wood GM, Stone DL, Chau D, Liu L, Stoffels M et al (2020) Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature 577:103\u2013108","journal-title":"Nature"},{"key":"5661_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","volume":"577","author":"P Tao","year":"2020","unstructured":"Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, Pan H, Bai R et al (2020) A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature 577:109\u2013114","journal-title":"Nature"},{"key":"5661_CR66","doi-asserted-by":"publisher","first-page":"16258","DOI":"10.1038\/nmicrobiol.2016.258","volume":"2","author":"JS Pearson","year":"2017","unstructured":"Pearson JS, Giogha C, M\u00fchlen S, Nachbur U, Pham CL, Zhang Y, Hildebrand JM, Oates CV et al (2017) EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation. Nat Microbiol 2:16258","journal-title":"Nat Microbiol"},{"key":"5661_CR67","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1038\/s41467-024-53306-1","volume":"15","author":"CY Yang","year":"2024","unstructured":"Yang CY, Tseng YC, Tu YF, Kuo BJ, Hsu LC, Lien CI, Lin YS, Wang YT et al (2024) Reverse hierarchical DED assembly in the cFLIP-procaspase-8 and cFLIP-procaspase-8-FADD complexes. Nat Commun 15:8974","journal-title":"Nat Commun"},{"key":"5661_CR68","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41556-024-01540-6","volume":"26","author":"T Zhang","year":"2024","unstructured":"Zhang T, Fu W, Zhang H, Li J, Xing B, Cai Y, Zhang M, Liu X et al (2024) Spermidine mediates acetylhypusination of RIPK1 to suppress diabetes onset and progression. Nat Cell Biol 26:2099\u20132114","journal-title":"Nat Cell Biol"},{"key":"5661_CR69","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1073\/pnas.1916427117","volume":"117","author":"MG Naito","year":"2020","unstructured":"Naito MG, Xu D, Amin P, Lee J, Wang H, Li W, Kelliher M, Pasparakis M et al (2020) Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke. Proc Natl Acad Sci U S A 117:4959\u20134970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR70","doi-asserted-by":"publisher","first-page":"e70085","DOI":"10.1002\/iid3.70085","volume":"12","author":"J Dong","year":"2024","unstructured":"Dong J, Xiong X (2024) Serum level of RIPK1\/3 correlated with the prognosis in ICU patients with acute ischemic stroke. Immun Inflamm Dis 12:e70085","journal-title":"Immun Inflamm Dis"},{"key":"5661_CR71","doi-asserted-by":"publisher","first-page":"12585","DOI":"10.1111\/jcmm.15820","volume":"24","author":"Y Jiao","year":"2020","unstructured":"Jiao Y, Wang J, Zhang H, Cao Y, Qu Y, Huang S, Kong X, Song C, et al. (2020) Inhibition of microglial receptor-interacting protein kinase 1 ameliorates neuroinflammation following cerebral ischaemic stroke. J Cell Mol Med 24:12585\u201312598","journal-title":"J Cell Mol Med"},{"key":"5661_CR72","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","volume":"10","author":"AQ Chen","year":"2019","unstructured":"Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, Xia YP, Jin HJ et al (2019) Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis 10:487","journal-title":"Cell Death Dis"},{"key":"5661_CR73","doi-asserted-by":"publisher","first-page":"e2219091120","DOI":"10.1073\/pnas.2219091120","volume":"120","author":"Y Li","year":"2023","unstructured":"Li Y, Zou C, Chen C, Li S, Zhu Z, Fan Q, Pang R, Li F et al (2023) Myeloid-derived MIF drives RIPK1-mediated cerebromicrovascular endothelial cell death to exacerbate ischemic brain injury. Proc Natl Acad Sci U S A 120:e2219091120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR74","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2014.04.018","volume":"157","author":"CP Dillon","year":"2014","unstructured":"Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL et al (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189\u20131202","journal-title":"Cell"},{"issue":"5\u20136","key":"5661_CR75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.312561.118","volume":"32","author":"B Shan","year":"2018","unstructured":"Shan B, Pan H, Najafov A, Yuan J (2018) Necroptosis in development and diseases. Genes Dev 32(5\u20136):327\u2013340. https:\/\/doi.org\/10.1101\/gad.312561.118","journal-title":"Genes Dev"},{"key":"5661_CR76","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrm3683","volume":"14","author":"D Ofengeim","year":"2013","unstructured":"Ofengeim D, Yuan J (2013) Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol 14:727\u2013736","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5661_CR77","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(95)90070-5","volume":"81","author":"H Hsu","year":"1995","unstructured":"Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495\u2013504","journal-title":"Cell"},{"key":"5661_CR78","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/0092-8674(95)90149-3","volume":"83","author":"M Rothe","year":"1995","unstructured":"Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV (1995) The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243\u20131252","journal-title":"Cell"},{"key":"5661_CR79","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41418-024-01355-w","volume":"31","author":"YG Chen","year":"2024","unstructured":"Chen YG, Rieser E, Bhamra A, Surinova S, Kreuzaler P, Ho MH, Tsai WC, Peltzer N et al (2024) LUBAC enables tumor-promoting LT\u03b2 receptor signaling by activating canonical NF-\u03baB. Cell Death Differ 31:1267\u20131284","journal-title":"Cell Death Differ"},{"key":"5661_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s44318-024-00291-2","volume":"44","author":"TD Fischer","year":"2025","unstructured":"Fischer TD, Bunker EN, Zhu PP, Le Guerrou\u00e9 F, Hadjian M, Dominguez-Martin E, Scavone F, Cohen R, et al. (2025) STING induces HOIP-mediated synthesis of M1 ubiquitin chains to stimulate NF-\u03baB signaling. EMBO J 44:141\u2013165","journal-title":"EMBO J"},{"key":"5661_CR81","doi-asserted-by":"publisher","unstructured":"Zein L, Dietrich M, Balta D, Bader V, Scheuer C, Zellner S, Weinelt N, Vandrey J, et al. (2025) Linear ubiquitination at damaged lysosomes induces local NFKB activation and controls cell survival. Autophagy 21(5):1075\u20131095. https:\/\/doi.org\/10.1080\/15548627.2024.2443945","DOI":"10.1080\/15548627.2024.2443945"},{"key":"5661_CR82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L, et al. (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15:535\u2013548","journal-title":"Mol Cell"},{"key":"5661_CR83","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ncb1384","volume":"8","author":"CJ Wu","year":"2006","unstructured":"Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8:398\u2013406","journal-title":"Nat Cell Biol"},{"key":"5661_CR84","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cub.2007.01.027","volume":"17","author":"MA O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell MA, Legarda-Addison D, Skountzos P, Yeh WC, Ting AT (2007) Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol 17:418\u2013424","journal-title":"Curr Biol"},{"key":"5661_CR85","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"CK Ea","year":"2006","unstructured":"Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22:245\u2013257","journal-title":"Mol Cell"},{"key":"5661_CR86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","volume":"8","author":"MA Kelliher","year":"1998","unstructured":"Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8:297\u2013303","journal-title":"Immunity"},{"key":"5661_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2011.09.003","volume":"44","author":"DR Green","year":"2011","unstructured":"Green DR, Oberst A, Dillon CP, Weinlich R, Salvesen GS (2011) RIPK-dependent necrosis and its regulation by caspases: a mystery in five acts. Mol Cell 44:9\u201316","journal-title":"Mol Cell"},{"key":"5661_CR88","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.apmr.2011.02.004","volume":"92","author":"VB Anderson","year":"2011","unstructured":"Anderson VB, Wee E (2011) Impaired joint proprioception at higher shoulder elevations in chronic rotator cuff pathology. Arch Phys Med Rehabil 92:1146\u20131151","journal-title":"Arch Phys Med Rehabil"},{"key":"5661_CR89","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, Liu ZG (2012) Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 109:5322\u20135327","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR90","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213\u2013227","journal-title":"Cell"},{"key":"5661_CR91","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M (2015) The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 16:689\u2013697","journal-title":"Nat Immunol"},{"key":"5661_CR92","doi-asserted-by":"publisher","first-page":"e2113872119","DOI":"10.1073\/pnas.2113872119","volume":"119","author":"HI Muendlein","year":"2022","unstructured":"Muendlein HI, Connolly WM, Magri Z, Jetton D, Smirnova I, Degterev A, Balachandran S, Poltorak A (2022) ZBP1 promotes inflammatory responses downstream of TLR3\/TLR4 via timely delivery of RIPK1 to TRIF. Proc Natl Acad Sci U S A 119:e2113872119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06871-8","volume":"15","author":"SJ Yow","year":"2024","unstructured":"Yow SJ, Rosli SN, Hutchinson PE, Chen KW (2024) Differential signalling requirements for RIPK1-dependent pyroptosis in neutrophils and macrophages. Cell Death Dis 15:479","journal-title":"Cell Death Dis"},{"key":"5661_CR94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fnins.2017.00583","volume":"11","author":"M Yang","year":"2017","unstructured":"Yang M, Lv Y, Tian X, Lou J, An R, Zhang Q, Li M, Xu L, et al. (2017) Neuroprotective effect of \u03b2-caryophyllene on cerebral ischemia-reperfusion injury via regulation of necroptotic neuronal death and inflammation: in vivo and in vitro. Front Neurosci 11:583","journal-title":"Front Neurosci"},{"key":"5661_CR95","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-021-03651-6","volume":"12","author":"K Stark","year":"2021","unstructured":"Stark K, Goncharov T, Varfolomeev E, Xie L, Ngu H, Peng I, Anderson KR, Verschueren E, et al. (2021) Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury. Cell Death Dis 12:379","journal-title":"Cell Death Dis"},{"key":"5661_CR96","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1007\/s12035-023-03728-7","volume":"61","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yang F, Duo K, Liu Y, Yu J, Wu Q, Cai Z (2024) The role of necroptosis in cerebral ischemic stroke. Mol Neurobiol 61:3882\u20133898","journal-title":"Mol Neurobiol"},{"key":"5661_CR97","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022791","volume":"10","author":"J Wang","year":"2021","unstructured":"Wang J, Zhong W, Su H, Xu J, Yang D, Liu X, Zhu YZ (2021) Histone methyltransferase Dot1L contributes to RIPK1 kinase-dependent apoptosis in cerebral ischemia\/reperfusion. J Am Heart Assoc 10:e022791","journal-title":"J Am Heart Assoc"},{"key":"5661_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020735","author":"EV Mitroshina","year":"2022","unstructured":"Mitroshina EV, Loginova MM, Yarkov RS, Urazov MD, Novozhilova MO, Krivonosov MI, Ivanchenko MV, Vedunova MV (2022) Inhibition of neuronal necroptosis mediated by RIPK1 provides neuroprotective effects on hypoxia and ischemia in vitro and in vivo. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020735","journal-title":"Int J Mol Sci"},{"key":"5661_CR99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2014.04.002","volume":"68","author":"M Vieira","year":"2014","unstructured":"Vieira M, Fernandes J, Carreto L, Anuncibay-Soto B, Santos M, Han J, Fern\u00e1ndez-L\u00f3pez A, Duarte CB et al (2014) Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol Dis 68:26\u201336","journal-title":"Neurobiol Dis"},{"key":"5661_CR100","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41467-019-13873-0","volume":"11","author":"JJ Wang","year":"2020","unstructured":"Wang JJ, Liu F, Yang F, Wang YZ, Qi X, Li Y, Hu Q, Zhu MX et al (2020) Disruption of auto-inhibition underlies conformational signaling of ASIC1a to induce neuronal necroptosis. Nat Commun 11:475","journal-title":"Nat Commun"},{"key":"5661_CR101","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroscience.2017.10.038","volume":"371","author":"Y Ni","year":"2018","unstructured":"Ni Y, Gu WW, Liu ZH, Zhu YM, Rong JG, Kent TA, Li M, Qiao SG et al (2018) RIP1K contributes to neuronal and astrocytic cell death in ischemic stroke via activating autophagic-lysosomal pathway. Neuroscience 371:60\u201374","journal-title":"Neuroscience"},{"key":"5661_CR102","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","volume":"81","author":"JE Burda","year":"2014","unstructured":"Burda JE, Sofroniew MV (2014) Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81:229\u2013248","journal-title":"Neuron"},{"key":"5661_CR103","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/glia.23136","volume":"65","author":"B Liu","year":"2017","unstructured":"Liu B, Teschemacher AG, Kasparov S (2017) Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders. Glia 65:1205\u20131226","journal-title":"Glia"},{"key":"5661_CR104","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","volume":"106","author":"AT Argaw","year":"2009","unstructured":"Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR (2009) VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 106:1977\u20131982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5661_CR105","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41401-023-01069-8","volume":"44","author":"HP Du","year":"2023","unstructured":"Du HP, Guo Y, Zhu YM, Gao DF, Lin B, Liu Y, Xu Y, Said A et al (2023) RIPK1 inhibition contributes to lysosomal membrane stabilization in ischemic astrocytes via a lysosomal Hsp70.1B-dependent mechanism. Acta Pharmacol Sin 44:1549\u20131563","journal-title":"Acta Pharmacol Sin"},{"key":"5661_CR106","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s12975-021-00888-3","volume":"12","author":"YM Zhu","year":"2021","unstructured":"Zhu YM, Lin L, Wei C, Guo Y, Qin Y, Li ZS, Kent TA, McCoy CE et al (2021) The key regulator of necroptosis, RIP1 kinase, contributes to the formation of astrogliosis and glial scar in ischemic stroke. Transl Stroke Res 12:991\u20131017","journal-title":"Transl Stroke Res"},{"key":"5661_CR107","first-page":"3103","volume":"22","author":"J Zhu","year":"2020","unstructured":"Zhu J, Yang LK, Wang QH, Lin W, Feng Y, Xu YP, Chen WL, Xiong K et al (2020) NDRG2 attenuates ischemia-induced astrocyte necroptosis via the repression of RIPK1. Mol Med Rep 22:3103\u20133110","journal-title":"Mol Med Rep"},{"key":"5661_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99:21\u201378","journal-title":"Physiol Rev"},{"key":"5661_CR109","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41593-019-0497-x","volume":"22","author":"RN Munji","year":"2019","unstructured":"Munji RN, Soung AL, Weiner GA, Sohet F, Semple BD, Trivedi A, Gimlin K, Kotoda M et al (2019) Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module. Nat Neurosci 22:1892\u20131902","journal-title":"Nat Neurosci"},{"key":"5661_CR110","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s12264-023-01068-z","volume":"39","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Shu X, Cao Q, Xu L, Wang Z, Li C, Xia S, Shao P, et al. (2023) Compound from Magnolia officinalis ameliorates white matter injury by promoting oligodendrocyte maturation in chronic cerebral ischemia models. Neurosci Bull 39:1497\u20131511","journal-title":"Neurosci Bull"},{"key":"5661_CR111","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.1007\/s12035-023-03755-4","volume":"61","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Xu Z, Guo JF, Shen SH (2024) Single-cell transcriptome reveals cell type-specific molecular pathology in a 2VO cerebral ischemic mouse model. Mol Neurobiol 61:5248\u20135264","journal-title":"Mol Neurobiol"},{"key":"5661_CR112","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s12035-024-04564-z","volume":"62","author":"H Xue","year":"2025","unstructured":"Xue H, Ding Z, Chen X, Yang X, Jia Y, Zhao P, Wu Z (2025) Dexmedetomidine improves long-term neurological outcomes by promoting oligodendrocyte genesis and myelination in neonatal rats following hypoxic-ischemic brain injury. Mol Neurobiol 62:4866\u20134880","journal-title":"Mol Neurobiol"},{"key":"5661_CR113","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1177\/0271678X241260100","volume":"44","author":"S Wang","year":"2024","unstructured":"Wang S, Li C, Kang X, Su X, Liu Y, Wang Y, Liu S, Deng X, et al. (2024) Agomelatine promotes differentiation of oligodendrocyte precursor cells and preserves white matter integrity after cerebral ischemic stroke. J Cereb Blood Flow Metab 44:1487\u20131500","journal-title":"J Cereb Blood Flow Metab"},{"key":"5661_CR114","doi-asserted-by":"publisher","first-page":"e13255","DOI":"10.1111\/bpa.13255","volume":"34","author":"J Janowska","year":"2024","unstructured":"Janowska J, Gargas J, Zajdel K, Wieteska M, Lipinski K, Ziemka-Nalecz M, Frontczak-Baniewicz M, Sypecka J (2024) Oligodendrocyte progenitor cells\u2019 fate after neonatal asphyxia-puzzling implications for the development of hypoxic-ischemic encephalopathy. Brain Pathol 34:e13255","journal-title":"Brain Pathol"},{"key":"5661_CR115","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/brain\/awae029","volume":"147","author":"YJ Cheng","year":"2024","unstructured":"Cheng YJ, Wang F, Feng J, Yu B, Wang B, Gao Q, Wang TY, Hu B, et al. (2024) Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke. Brain 147:1294\u20131311","journal-title":"Brain"},{"key":"5661_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuroscience.2017.12.007","volume":"371","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang L, Yu H, Song K, Shi J, Chen L, Cheng J (2018) Necrostatin-1 improves long-term functional recovery through protecting oligodendrocyte precursor cells after transient focal cerebral ischemia in mice. Neuroscience 371:229\u2013241","journal-title":"Neuroscience"},{"key":"5661_CR117","doi-asserted-by":"publisher","first-page":"1159743","DOI":"10.3389\/fimmu.2023.1159743","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Yuan J (2023) Targeting RIPK1 kinase for modulating inflammation in human diseases. Front Immunol 14:1159743","journal-title":"Front Immunol"},{"key":"5661_CR118","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/imm.13795","volume":"172","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou Y, Xi S, Han D, Wang Z, Zhu J, Cai Y, Zhang H, et al. (2024) The TRIF-RIPK1-Caspase-8 signalling in the regulation of TLR4-driven gene expression. Immunology 172:566\u2013576","journal-title":"Immunology"},{"key":"5661_CR119","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.immuni.2016.06.007","volume":"45","author":"M Najjar","year":"2016","unstructured":"Najjar M, Saleh D, Zelic M, Nogusa S, Shah S, Tai A, Finger JN, Polykratis A, et al. (2016) RIPK1 and RIPK3 kinases promote cell-death-independent inflammation by Toll-like receptor 4. Immunity 45:46\u201359","journal-title":"Immunity"},{"key":"5661_CR120","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41419-018-1053-4","volume":"9","author":"J Buchrieser","year":"2018","unstructured":"Buchrieser J, Oliva-Martin MJ, Moore MD, Long JCD, Cowley SA, Perez-Sim\u00f3n JA, James W, Venero JL (2018) RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation. Cell Death Dis 9:973","journal-title":"Cell Death Dis"},{"key":"5661_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112182","volume":"134","author":"D Guo","year":"2024","unstructured":"Guo D, Hu L, Xie P, Sun P, Yu W (2024) Seipin is involved in oxygen-glucose deprivation\/reoxygenation induced neuroinflammation by regulating the TLR3\/TRAF3\/NF-\u03baB pathway. Int Immunopharmacol 134:112182","journal-title":"Int Immunopharmacol"},{"key":"5661_CR122","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/01616412.2021.1910904","volume":"43","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Wills M, Geng X, Ding Y (2021) Chlorpromazine and promethazine reduces brain injury through RIP1-RIP3 regulated activation of NLRP3 inflammasome following ischemic stroke. Neurol Res 43:668\u2013676","journal-title":"Neurol Res"},{"key":"5661_CR123","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6814393","volume":"2018","author":"Y Xu","year":"2018","unstructured":"Xu Y, Zhang J, Ma L, Zhao S, Li S, Huang T, Chu Z (2018) The pathogenesis of necroptosis-dependent signaling pathway in cerebral ischemic disease. Behav Neurol 2018:6814393","journal-title":"Behav Neurol"},{"key":"5661_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121885","author":"Y Rajesh","year":"2022","unstructured":"Rajesh Y, Kanneganti TD (2022) Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells11121885","journal-title":"Cells"},{"key":"5661_CR125","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.redox.2024.103169","volume":"73","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Ding Y, Li F, Fayyaz AI, Duan H, Geng X (2024) Modulation of NLRP3 inflammasome-related-inflammation via RIPK1\/RIPK3-DRP1 or HIF-1\u03b1 signaling by phenothiazine in hypothermic and normothermic neuroprotection after acute ischemic stroke. Redox Biol 73:103169","journal-title":"Redox Biol"},{"key":"5661_CR126","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","volume":"179","author":"M Prinz","year":"2019","unstructured":"Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179:292\u2013311","journal-title":"Cell"},{"key":"5661_CR127","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","volume":"54","author":"K Borst","year":"2021","unstructured":"Borst K, Dumas AA, Prinz M (2021) Microglia: immune and non-immune functions. Immunity 54:2194\u20132208","journal-title":"Immunity"},{"key":"5661_CR128","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12916-024-03517-6","volume":"22","author":"Y Qu","year":"2024","unstructured":"Qu Y, Jin H, Abuduxukuer R, Qi S, Si XK, Zhang P, Zhang KJ, Wang SJ, et al. (2024) The association between serum S100\u03b2 levels and prognosis in acute stroke patients after intravenous thrombolysis: a multicenter prospective cohort study. BMC Med 22:304","journal-title":"BMC Med"},{"key":"5661_CR129","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/01616412.2016.1152675","volume":"38","author":"S Zhou","year":"2016","unstructured":"Zhou S, Bao J, Wang Y, Pan S (2016) S100\u03b2 as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke. Neurol Res 38:327\u2013332","journal-title":"Neurol Res"},{"key":"5661_CR130","doi-asserted-by":"publisher","first-page":"619721","DOI":"10.3389\/fneur.2021.619721","volume":"12","author":"M Dagonnier","year":"2021","unstructured":"Dagonnier M, Donnan GA, Davis SM, Dewey HM, Howells DW (2021) Acute stroke biomarkers: are we there yet? Front Neurol 12:619721","journal-title":"Front Neurol"},{"key":"5661_CR131","doi-asserted-by":"publisher","first-page":"634717","DOI":"10.3389\/fneur.2021.634717","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Yang C, Wang X, Xiang Y (2021) Blood-based biomarkers: a forgotten friend of hyperacute ischemic stroke. Front Neurol 12:634717","journal-title":"Front Neurol"},{"key":"5661_CR132","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10557-007-6035-1","volume":"21","author":"CC Smith","year":"2007","unstructured":"Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM (2007) Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21:227\u2013233","journal-title":"Cardiovasc Drugs Ther"},{"key":"5661_CR133","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1038\/cddis.2012.64","volume":"3","author":"DE Christofferson","year":"2012","unstructured":"Christofferson DE, Li Y, Hitomi J, Zhou W, Upperman C, Zhu H, Gerber SA, Gygi S, et al. (2012) A novel role for RIP1 kinase in mediating TNF\u03b1 production. Cell Death Dis 3:e320","journal-title":"Cell Death Dis"},{"key":"5661_CR134","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/cdd.2012.151","volume":"20","author":"P Vandenabeele","year":"2013","unstructured":"Vandenabeele P, Grootjans S, Callewaert N, Takahashi N (2013) Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ 20:185\u2013187","journal-title":"Cell Death Differ"},{"key":"5661_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023209","volume":"6","author":"Y Cho","year":"2011","unstructured":"Cho Y, McQuade T, Zhang H, Zhang J, Chan FK (2011) RIP1-dependent and independent effects of necrostatin-1 in necrosis and T cell activation. PLoS ONE 6:e23209","journal-title":"PLoS ONE"},{"key":"5661_CR136","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1016\/j.febslet.2011.08.028","volume":"585","author":"Y Tamura","year":"2011","unstructured":"Tamura Y, Chiba Y, Tanioka T, Shimizu N, Shinozaki S, Yamada M, Kaneki K, Mori S et al (2011) No donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic \u03b2-cells. FEBS Lett 585:3058\u20133064","journal-title":"FEBS Lett"},{"key":"5661_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.176","volume":"3","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R et al (2012) Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 3:e437","journal-title":"Cell Death Dis"},{"key":"5661_CR138","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/cddiscovery.2015.9","volume":"1","author":"SB Berger","year":"2015","unstructured":"Berger SB, Harris P, Nagilla R, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M et al (2015) Characterization of GSK\u2019963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discov 1:15009","journal-title":"Cell Death Discov"},{"key":"5661_CR139","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1021\/acs.jmedchem.5b01898","volume":"59","author":"PA Harris","year":"2016","unstructured":"Harris PA, King BW, Bandyopadhyay D, Berger SB, Campobasso N, Capriotti CA, Cox JA, Dare L et al (2016) DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors. J Med Chem 59:2163\u20132178","journal-title":"J Med Chem"},{"key":"5661_CR140","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","volume":"60","author":"PA Harris","year":"2017","unstructured":"Harris PA, Berger SB, Jeong JU, Nagilla R, Bandyopadhyay D, Campobasso N, Capriotti CA, Cox JA, et al. (2017) Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases. J Med Chem 60:1247\u20131261","journal-title":"J Med Chem"},{"key":"5661_CR141","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13075-021-02468-0","volume":"23","author":"K Weisel","year":"2021","unstructured":"Weisel K, Berger S, Thorn K, Taylor PC, Peterfy C, Siddall H, Tompson D, Wang S, et al. (2021) A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis. Arthritis Res Ther 23:85","journal-title":"Arthritis Res Ther"},{"key":"5661_CR142","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cpt.1852","volume":"108","author":"K Weisel","year":"2020","unstructured":"Weisel K, Berger S, Papp K, Maari C, Krueger JG, Scott N, Tompson D, Wang S, et al. (2020) Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study. Clin Pharmacol Ther 108:808\u2013816","journal-title":"Clin Pharmacol Ther"},{"key":"5661_CR143","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13318-020-00652-2","volume":"46","author":"DJ Tompson","year":"2021","unstructured":"Tompson DJ, Davies C, Scott NE, Cannons EP, Kostapanos M, Gross AS, Powell M, Ino H, et al. (2021) Comparison of the pharmacokinetics of RIPK1 inhibitor GSK2982772 in healthy Western and Japanese subjects. Eur J Drug Metab Pharmacokinet 46:71\u201383","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"5661_CR144","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000680","volume":"8","author":"K Weisel","year":"2021","unstructured":"Weisel K, Scott N, Berger S, Wang S, Brown K, Powell M, Broer M, Watts C et al (2021) A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. BMJ Open Gastroenterol 8(1):e000680","journal-title":"BMJ Open Gastroenterol"},{"key":"5661_CR145","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/cpt.1615","volume":"107","author":"HW Grievink","year":"2020","unstructured":"Grievink HW, Heuberger J, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, et al. (2020) DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers. Clin Pharmacol Ther 107:406\u2013414","journal-title":"Clin Pharmacol Ther"},{"key":"5661_CR146","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20:19\u201333","journal-title":"Nat Rev Neurosci"},{"key":"5661_CR147","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/cts.13317","volume":"15","author":"M Vissers","year":"2022","unstructured":"Vissers M, Heuberger J, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM et al (2022) Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: randomized, placebo-controlled, double-blind phase I\/Ib studies in healthy subjects and patients. Clin Transl Sci 15:2010\u20132023","journal-title":"Clin Transl Sci"},{"key":"5661_CR148","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12931-024-02670-z","volume":"25","author":"PF Clot","year":"2024","unstructured":"Clot PF, Farenc C, Suratt BT, Krahnke T, Tardat A, Florian P, Pomponio R, Patel N et al (2024) Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study. Respir Res 25:107","journal-title":"Respir Res"},{"key":"5661_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13690","volume":"17","author":"A Hincelin-Mery","year":"2024","unstructured":"Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M, Ofengeim D, Krupka E et al (2024) Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants. Clin Transl Sci 17:e13690","journal-title":"Clin Transl Sci"},{"key":"5661_CR150","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1182\/blood.2022017262","volume":"141","author":"X Yu","year":"2023","unstructured":"Yu X, Ma H, Li B, Ji Y, Du Y, Liu S, Li Z, Hao Y et al (2023) A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis. Blood 141:1070\u20131086","journal-title":"Blood"},{"key":"5661_CR151","first-page":"3430","volume":"76","author":"E Hanson","year":"2024","unstructured":"Hanson E, Dairaghi D, Vendel AC, Sims J, Takita Y, Yan L, Chow A, Shaw S et al (2024) Early development of Ocadusertib, a selective receptor-interacting serine\/threonine-protein kinase 1 inhibitor. Arthritis Rheumatol 76:3430\u20133431","journal-title":"Arthritis Rheumatol"},{"key":"5661_CR152","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/cts.13580","volume":"16","author":"J Lickliter","year":"2023","unstructured":"Lickliter J, Wang S, Zhang W, Zhu H, Wang J, Zhao C, Shen H, Wang Y (2023) A phase I randomized, double-blinded, placebo-controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects. Clin Transl Sci 16:1691\u20131703","journal-title":"Clin Transl Sci"},{"issue":"01","key":"5661_CR153","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jointm.2024.07.003","volume":"5","author":"N Chavez-Tapia","year":"2024","unstructured":"Chavez-Tapia N, Sayeed MA, Luxmi S, Kasper DJ, Xue F, Shen Y, Fan W, Yuan W et al (2024) Safety and efficacy of selective RIPK1 inhibitor SIR1\u2013365 in hospitalized patients with severe COVID-19: A multicenter, randomized, double-blind, phase 1b trial. J Intensive Med 5(01):70\u20138","journal-title":"J Intensive Med"},{"key":"5661_CR154","doi-asserted-by":"publisher","first-page":"e13857","DOI":"10.1111\/cts.13857","volume":"17","author":"ALA Sun","year":"2024","unstructured":"Sun ALA, Gillies JD, Shen Y, Deng H, Xue F, Ma Y, Song L (2024) A phase I randomized study to evaluate safety, pharmacokinetics, and pharmacodynamics of SIR2446M, a selective RIPK1 inhibitor, in healthy participants. Clin Transl Sci 17:e13857","journal-title":"Clin Transl Sci"},{"issue":"9","key":"5661_CR155","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/biomedicines13092085","volume":"13","author":"MH Tran","year":"2025","unstructured":"Tran MH, Parris CL, Liu C, Oropeza A, Esquivel C, Rani A, Fan Y, Fu L et al (2025) Sex Differences in the Initiation and Progression of Necroptosis Following Kidney Ischemia-Reperfusion Injury. Biomedicines 13(9):2085. https:\/\/doi.org\/10.3390\/biomedicines13092085","journal-title":"Biomedicines"},{"key":"5661_CR156","doi-asserted-by":"publisher","first-page":"111906","DOI":"10.1016\/j.isci.2025.111906","volume":"28","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Hu X, Guo C, Xu Y, Li S, Wen W, Hu X, Zeng F, et al. (2025) Reduction of intestinal RIPK1 ameliorates HFD-induced metabolic disorders in female mice. iScience 28:111906","journal-title":"iScience"},{"issue":"6","key":"5661_CR157","doi-asserted-by":"publisher","first-page":"e00365","DOI":"10.1002\/prp2.365","volume":"5","author":"K Weisel","year":"2017","unstructured":"Weisel K, Scott NE, Tompson DJ, Votta BJ, Madhavan S, Povey K, Wolstenholme A, Simeoni M et al (2017) Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers. Pharmacol Res Perspect 5(6):e00365","journal-title":"Pharmacol Res Perspect"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05661-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05661-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:01:28Z","timestamp":1768424488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05661-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":157,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5661"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05661-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors approved the final version of the manuscript and agreed to be accountable for all aspects of the work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"363"}}